Caricamento...
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
Ulcerative colitis (UC) still has no definitive cure since its etiology remains unclear. In recent years, considerable progress has been made with regard to our knowledge of the pathogenesis of UC. Advances in biotechnology have led to the development of biologic therapies which selectively target s...
Salvato in:
| Pubblicato in: | Biologics |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6497489/ https://ncbi.nlm.nih.gov/pubmed/31114154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S179006 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|